Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
2.570
+0.060 (2.39%)
Feb 3, 2026, 12:13 PM EST - Market open
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $166.41 million as of February 3, 2026. Its market cap has decreased by -2.30% in one year.
Market Cap
166.41M
Enterprise Value
-79.01M
1-Year Change
-2.30%
Ranking
Category
Stock Price
$2.57
Market Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has decreased from $587.46M to $166.41M, a decrease of -71.67%. That is a compound annual growth rate of -19.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 162.52M | 85.93% |
| Dec 31, 2025 | 87.41M | -59.52% |
| Dec 31, 2024 | 215.93M | -79.86% |
| Dec 29, 2023 | 1.07B | -6.72% |
| Dec 30, 2022 | 1.15B | -69.82% |
| Dec 31, 2021 | 3.81B | 80.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innate Pharma | 171.43M |
| Kalaris Therapeutics | 170.38M |
| Molecular Partners AG | 170.21M |
| Compugen | 169.30M |
| Prelude Therapeutics | 167.27M |
| ProQR Therapeutics | 163.29M |
| Century Therapeutics | 160.83M |
| Opus Genetics | 160.00M |